100% Quality Guarantee
PhD-Level Technical Support
Anti-4-1BB utomilumab biosimilar mAb HDBS0037
Key Features

Utomilumab Biosimilar (4-1BB) Antibody (HDBS0037)

SKU HDBS0037
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein 4-1BB
Reactivity Human
Host Species Human
Isotype IgG2
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Utomilumab Biosimilar (4-1BB) Antibody (HDBS0037)

The 4-1BB (Utomilumab) Biosimilar MAb (HDBS0037) is a monoclonal antibody designed for research involving the 4-1BB (Utomilumab) protein, a cell surface molecule involved in immune regulation and activation of T cells. This antibody, developed and validated by Assay Genie, is highly specific and shows high affinity for the 4-1BB (Utomilumab) protein in human samples.The 4-1BB (Utomilumab) Biosimilar MAb (HDBS0037) is ideal for use in various research applications, including Western blotting, immunohistochemistry, and flow cytometry. Its ability to bind specifically to the 4-1BB (Utomilumab) protein allows for accurate detection and analysis in different cell types, making it valuable for studies in immunology, cancer research, and autoimmune diseases.

The 4-1BB (Utomilumab) protein is a promising target for immunotherapy and cancer treatment, as it plays a crucial role in promoting T cell activation and enhancing anti-tumor immune responses. By understanding the function and regulation of 4-1BB (Utomilumab), researchers can develop novel therapies and strategies to combat cancer and other immune-related diseases. The Anti-4-1BB (Utomilumab) Biosimilar MAb (HDBS003

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose